当前位置: X-MOL 学术Arch. Pharm. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Further Developments
Archiv der Pharmazie ( IF 5.1 ) Pub Date : 2017-01-01 , DOI: 10.1002/ardp.201770010
Holger Stark

Although the Archiv der Pharmazie Chemistry in Life Sciences is one of the oldest publication organs in Medicinal Chemistry [1], it is still evolving, making further progress. The impact factor of this journal has again markedly increased. The new Advisory Board members, who have taken up their jobs in 2016, are already well established. The online-only publication allows the inclusion of colored graphics and also other file formats without additional costs for the authors. Several topical review articles have been published, covering heterogeneous topics like epigenetics in cancer [2], heterocyclic tyrosine kinase inhibitors [3], biomarkers [4], beta-cell regulators [5], privileged scaffolds [6], alternative antibiotics [7], antimycobacterial metabolites [8] or enzyme-oriented antimycotics [9], covalent inhibitors [10], heterologous antibiotic production [11] as well as tool boxes [12] or PPP models in drug discovery [13], not to mention the numerous excellent original papers. Therefore, I would like to thank all authors for their valuable contributions and all reviewers for their careful and most helpful support. The information package published togetherwith the articles has been extended by the additional structural SMILES codes in combination with biological activity data in the Supplementary Material and will now further include the eLocator function for the references of online-only articles. In 2017, we will celebrate the centenarian article by Carl Mannich on his important amino alkylation reaction with carbonyl compounds, published in this journal in 1917 [14, 15]. With this and many other coming highlights we do see this journal on a good way. Many thanks for your continuous support!

中文翻译:

进一步发展

虽然 Archiv der Pharmazie Chemistry in Life Sciences 是 Medicinal Chemistry 领域最古老的出版机构之一 [1],但它仍在不断发展,取得进一步进展。这个期刊的影响因子又明显提高了。2016 年上任的新顾问委员会成员已经成熟。仅在线出版物允许包含彩色图形和其他文件格式,而不会给作者带来额外费用。已发表多篇专题评论文章,涵盖异质主题,如癌症中的表观遗传学 [2]、杂环酪氨酸激酶抑制剂 [3]、生物标志物 [4]、β 细胞调节剂 [5]、特权支架 [6]、替代抗生素 [7] ]、抗分枝杆菌代谢物 [8] 或酶导向抗真菌药 [9]、共价抑制剂 [10]、异源抗生素生产 [11] 以及药物发现中的工具箱 [12] 或 PPP 模型 [13],更不用说众多优秀的原创论文了。因此,我要感谢所有作者的宝贵贡献和所有审稿人的细心和最有帮助的支持。与文章一起发布的信息包已通过附加结构 SMILES 代码与补充材料中的生物活性数据进行了扩展,现在将进一步包括用于在线文章参考的 eLocator 功能。2017 年,我们将庆祝 Carl Mannich 于 1917 年在该杂志上发表的关于他与羰基化合物的重要氨基烷基化反应的百岁文章 [14, 15]。有了这个和许多其他即将到来的亮点,我们确实看到了这本期刊的良好方式。
更新日期:2017-01-01
down
wechat
bug